GlassScriptPhysician profile
Kathryn Magoon Link
NPI 1821592411
$1,462.99
in general payments reported to CMS, 2019-2025
16 companies · $463 in 2025
The $463 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $169 · 2022: $565 · 2023: $185 · 2024: $80.74 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $359.51 | 2025 | Rapiblyk |
| Astrazeneca Pharmaceuticals LP | $179.11 | 2022-2023 | Farxiga |
| Atricure, INC. | $169.92 | 2022 | |
| Abbott Laboratories | $152.58 | 2022 | |
| Janssen Pharmaceuticals, INC | $100.49 | 2022-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.95 | 2021 | |
| Pfizer INC. | $90.46 | 2022-2025 | |
| Medtronic, INC. | $69.53 | 2021 | |
| Novartis Pharmaceuticals Corporation | $54.14 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $47.46 | 2024-2025 | Verquvo |
| Edwards Lifesciences Corporation | $32.57 | 2023 | Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $28.93 | 2022-2024 | |
| Esperion Therapeutics, INC. | $25.18 | 2023 | Nexletol |
| Philips North America LLC | $20.19 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Alnylam Pharmaceuticals INC. | $18.05 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.92 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Link listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.